12:00 AM
 | 
May 04, 2009
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

InflaRx GmbH

Jena, Germany

Technology: Antibodies against complement activation products

Disease focus: Infectious, inflammation

Clinical status:...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >